Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
Expires | Type | Strike | OI | Change | Percent |
---|---|---|---|---|---|
08/15/2025 | CALL | $83.00 | 2,415 | +2,029 | +525.65% |
08/08/2025 | CALL | $80.00 | 1,904 | +1,590 | +506.37% |
08/08/2025 | CALL | $82.00 | 1,787 | +1,276 | +249.71% |
08/01/2025 | PUT | $77.00 | 2,975 | +1,269 | +74.38% |
06/18/2026 | PUT | $70.00 | 6,066 | +610 | +11.18% |
08/08/2025 | PUT | $77.00 | 807 | +464 | +135.28% |
08/01/2025 | PUT | $79.00 | 629 | -216 | -25.56% |
08/01/2025 | CALL | $82.00 | 4,044 | -253 | -5.89% |
08/15/2025 | CALL | $95.00 | 26,684 | -309 | -1.14% |
08/01/2025 | PUT | $83.00 | 802 | -472 | -37.05% |
08/15/2025 | PUT | $90.00 | 843 | -503 | -37.37% |
08/01/2025 | PUT | $84.00 | 529 | -1,027 | -66.00% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
Name | Pct Held | Shares | Total |
---|---|---|---|
Vanguard Total Stock Market Index Fund | 3.04% | 77.07M | 8.28B |
Vanguard 500 Index Fund | 2.31% | 58.61M | 6.3B |
Fidelity 500 Index Fund | 1.09% | 27.79M | 2.99B |
SPDR S&P 500 ETF Trust | 1.08% | 27.45M | 2.95B |
iShares Core S&P 500 ETF | 0.89% | 22.63M | 2.43B |
Vanguard Index-Value Index Fund | 0.86% | 21.91M | 2.35B |
Select Sector SPDR Fund-Health Care | 0.81% | 20.59M | 2.21B |
Vanguard Specialized-Health Care Fund | 0.72% | 18.31M | 1.97B |
Vanguard Institutional Index Fund-Institutional Index Fund | 0.70% | 17.77M | 1.91B |
Schwab Strategic Tr-Schwab U.S. Dividend Equity ETF | 0.68% | 17.38M | 1.87B |
Ascentage Pharma to Participate in Evercore China Biotech Summit
08/01 08:00 am
GlobeNewswire Inc.
Read moreTesticular Cancer Market Analysis and Forecast Report 2025-2035 | Emerging Trends Highlight Shift Towards Immunotherapy in Testicular Cancer
08/01 04:51 am
GlobeNewswire Inc.
Read moreDrug Discovery Platforms Market Size Expected to Reach USD 635.45 Million by 2034
07/30 10:00 am
GlobeNewswire Inc.
Read moreAdrenocortical Carcinoma Market Forecast upto 2034—Insights into Emerging Therapies and Market Trends | DelveInsight
07/29 01:00 pm
GlobeNewswire Inc.
Read moreMerck Q2: EPS Beats, but Sales Flat as Vaccine Demand Slips Globally
07/29 11:19 am
Investing.com
Read moreTherini Bio Announces First Patient Dosed in Phase 1b Trial of THN391 in Alzheimer’s Disease
07/29 08:00 am
GlobeNewswire Inc.
Read moreThis Beaten-Down Healthcare Stock Could Jump 720%, According to a Wall Street Analyst. Is It Time to Buy?
07/29 03:29 am
The Motley Fool
Read moreAfter Merck, Chinese Biotech Hengrui Pharma Collaborates With GSK In Worth $12 Billion Pact
07/28 11:32 am
Benzinga
Read moreOncology Drugs Market Insights, Competitive Landscape, and Forecast Report 2025-2032 | Immunotherapy Leads Growth in Oncology Market Due to Better Precision and Fewer Side Effects
07/25 10:50 am
GlobeNewswire Inc.
Read moreNon-Hodgkin’s Lymphoma Market Forecast to Surge with Growing Adoption of Targeted and Cell-Based Therapies | DelveInsight
07/24 01:00 pm
GlobeNewswire Inc.
Read moreShould You Forget Pfizer and Buy This Magnificent Dividend Stock Instead?
07/20 09:25 am
The Motley Fool
Read moreMERCK ALERT: Bragar Eagel & Squire, P.C. is Investigating Merck & Co., Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
07/19 02:54 pm
GlobeNewswire Inc.
Read moreEuropean Commission Grants Conditional Approval of EZMEKLY® (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN
07/18 11:30 am
GlobeNewswire Inc.
Read moreOrion-konsernin puolivuosikatsaus tammi–kesäkuu 2025
07/18 05:00 am
GlobeNewswire Inc.
Read moreMerck Just Announced a $10 Billion Deal That Will Help Diversify Its Business
07/17 08:15 am
The Motley Fool
Read moreAdagene Announces Regulatory Update on Clinical Development Plan for Muzastotug in Microsatellite Stable Colorectal Cancer Following Productive Type B (End of Phase 1) Meeting with FDA
07/15 07:00 am
GlobeNewswire Inc.
Read moreWaldenstrom Macroglobulinemia Market Sees Surging Demand Across the 7MM Amid BTK Inhibitor Advancements | DelveInsight
07/14 01:00 pm
GlobeNewswire Inc.
Read moreAstraZeneca's Drug Shows Promise For Resistant Hypertension In Phase 3 Trial
07/14 09:05 am
Benzinga
Read moreEpitopea renforce ses capacités de recherche et de développement clinique pour accélérer le passage à la clinique
07/10 04:00 am
GlobeNewswire Inc.
Read moreEpitopea Expands its Clinical Development and Research Capabilities as it Accelerates to the Clinic
07/10 04:00 am
GlobeNewswire Inc.
Read moreNvidia's $4 Trillion Milestone Lifts Wall Street: What's Moving Markets Wednesday?
07/09 02:19 pm
Benzinga
Read moreMerck Strikes $10-Billion Deal For Verona, Secures First-In-Class COPD Drug
07/09 09:03 am
Benzinga
Read moreFood Pathogen Testing Market Trends, Analysis, and Forecast 2025-2034 | CRISPR and Lab-on-a-Chip Technologies Set to Revolutionize Pathogen Detection
07/04 04:56 am
GlobeNewswire Inc.
Read moreSodium Perborate Market worth $184.0 million in 2030, at 3.7%, says MarketsandMarkets™
07/04 04:00 am
GlobeNewswire Inc.
Read more3 Absurdly Cheap Stocks Ready for a Breakout
06/28 10:09 am
The Motley Fool
Read moreRFK Jr's CDC Panel Recommends Merck's RSV Shot For Infants
06/27 07:56 am
Benzinga
Read moreMedicenna Therapeutics Reports Fiscal Year 2025 Financial Results and Operational Highlights
06/26 07:00 am
GlobeNewswire Inc.
Read more2 Dividend Stocks to Buy and Never Sell
06/18 05:02 am
The Motley Fool
Read moreThese Were the 2 Worst-Performing Stocks in the Dow Jones Industrial Average in May 2025
06/14 08:02 am
The Motley Fool
Read moreMerck's Keytruda Secures FDA Nod For Head And Neck Cancer As First Immunotherapy For Use Around Surgery
06/13 02:08 pm
Benzinga
Read moreWhy Summit Therapeutics Stock Tanked Today
06/11 05:28 pm
The Motley Fool
Read morePenicillin Market Research Report 2025 - Global $12.5+ Bn Trends, Opportunities, and Forecasts, 2020-2030F
05/29 10:58 am
GlobeNewswire Inc.
Read moreRapid Micro Biosystems Announces Appointment of Dr. Dafni Bika to Board of Directors
05/27 09:00 am
GlobeNewswire Inc.
Read moreMRK Down 21% YTD: Should You Buy, Hold or Sell the Stock?
05/26 11:01 am
Zacks Investment Research
Read more3 Deep-Value Stocks to Buy as Bulls Take a Breather
05/22 10:16 am
Investing.com
Read moreModerna Stock Looks Ripe for a Short Squeeze
05/22 08:21 am
Investing.com
Read moreEvaxion doses first patient in extension of phase 2 trial exploring the full potential of AI-designed personalized cancer vaccine EVX-01
05/22 08:00 am
GlobeNewswire Inc.
Read moreAplastic Anemia Global Clinical Trials Review, 2025 | Explore Trends and Enrollment Data in Aplastic Anemia Clinical Trials
05/20 06:59 am
GlobeNewswire Inc.
Read moreBio/Pharmaceutical Outsourcing Report, March 2025 Edition - Trump Tariffs Drive Pharma Manufacturing to US but Risk Inflation and Disruption
05/19 10:56 am
GlobeNewswire Inc.
Read moreNeurofibromatosis Type 1 Market Set to Witness Significant Growth During the Study Period (2020–2034) Driven by Advances in Treatment | DelveInsight
05/15 01:00 pm
GlobeNewswire Inc.
Read more3 Absurdly Cheap Stocks Trading Near Their 52-Week Lows
05/14 11:31 am
The Motley Fool
Read moreTILT Biotherapeutics Announces Closing of USD 25 Million Series B Financing
05/13 03:00 am
GlobeNewswire Inc.
Read moreBlood Cancer Treatment Market Sees Accelerated Growth Across the 7MM Amid Rising Incidence and Breakthroughs | DelveInsight
05/12 01:00 pm
GlobeNewswire Inc.
Read more2 Beaten-Down Stocks That Are Great Buys on the Dip
05/08 09:12 am
The Motley Fool
Read moreCan Summit Therapeutics Stock Double Your Money?
05/07 09:30 am
The Motley Fool
Read moreMultiple System Atrophy (MSA) Market Research 2025-2035 - Emerging Alpha-Synuclein Therapies and Strategic Pharma Collaborations Propel MSA Market Towards Disease-Modifying Breakthroughs
05/07 04:41 am
GlobeNewswire Inc.
Read moreLiver Cancer Treatment Market is expected to generate a revenue of USD 8.88 Billion by 2031, Globally, at 13.45% CAGR: Verified Market Research®
05/02 10:00 am
GlobeNewswire Inc.
Read moreThis Soaring Stock Just Delivered More Good News. Time to Buy?
05/02 08:30 am
The Motley Fool
Read more